writing on the wall?, page-9

$11M cap, $1M+ in cash and cash equivalents

Taiwan likely to generate up to $8M per year after ramp up

Brazil once signed expected to bring in up to $4M per year

Major in Europe requested product for testing

Major in US already tested product, favorable result and awaiting outcome of Brazil

Launching new PeriCoach device that does not require FDA approval, distribution, negotiations with majors - a pure marketing play

Yes ntsusu, I prefer to look at fundamentals and what is happening next week (broker presentation and roadshow) and coming weeks (launch of PeriCoach, Brazil distribution) as opposed to the $19k of sales today.

Anyone selling due to expecting a CR should remember the last one was at a 10% premium, of which the directors underwrote 30% or $1M+ and no CR price has been set.